Health Atlas
Menu
Evidence-led reference

Prevention & care

Eczema and atopic dermatitis: types, skin barrier, treatments, and food claims

8 sources · Latest source check 2026-10-20 UTC
On this page

Eczema is an umbrella term for several inflammatory skin conditions. Atopic dermatitis is one common form; contact dermatitis, dyshidrotic eczema and stasis dermatitis are other categories. Similar itching or inflammation does not make every eczema type the same disease, and the cause affects management.[1]

Common names refer to different patterns

Common names refer to different patterns
NameWhat distinguishes itScope of this page
Atopic dermatitisChronic itchy inflammatory disease involving immune and skin-barrier factors.The main condition explained below.[2]
Contact dermatitisSkin reacts to contact with a substance.Requires identifying the relevant exposure and mechanism.[1]
Dyshidrotic eczemaA blistering pattern typically affecting hands or feet.A different pattern from assuming every itchy patch is atopic.[1]
Stasis dermatitisInflammation related to circulation problems, usually in the legs.The underlying circulation issue matters.[1]

Barrier, inflammation, and the itch–scratch cycle

NIAMS describes interacting genetic, immune and environmental factors. Itching and scratching can worsen the skin damage and disturb sleep. Atopic dermatitis often begins in childhood, but can persist or begin in adulthood. It is not contagious and is not proof that someone has failed to keep their skin clean.[2]

Appearance and distribution can vary with age and skin tone. Inflamed skin is not always bright red, and colour changes may remain after active inflammation improves. This matters when assessing a photograph or comparing someone’s skin with a single stock image; appearance alone cannot reliably identify every diagnosis.[2]

A diagnosis is more than an itch or a test panel

Assessment considers the history, pattern, examination and possible alternative causes. Selected tests can clarify a particular question, but there is no single broad blood panel that independently explains every eczema flare. Allergy assessment is a separate clinical question when the history indicates a possible reaction.[3]

AAD distinguishes several eczema types because identifying the pattern can change treatment. Exposure-related inflammation and inflammation related to poor leg circulation should not be assigned the same mechanism simply because both can itch. This page’s atopic-dermatitis discussion does not provide a treatment pathway for every eczema subtype.[1]

Moisturising and controlling inflammation have different roles

Moisturisers help support the skin barrier; anti-inflammatory medicines address active inflammation. AAD describes these as complementary roles rather than interchangeable products. Product tolerance, application plans and the extent of disease matter, so “more moisturiser” does not explain every persistent flare.[4]

NIAMS describes topical medicines and, for selected more severe cases, phototherapy or systemic medicines. Options differ by age, severity, location and safety considerations. A treatment approved for one population is not automatically appropriate for every child or every rash. Monitoring and instructions are part of the treatment, not optional details.[3]

The AAD patient explanation discusses a range of treatments, but it is not an independent trial comparison performed by this project. It acknowledges financial support from Sanofi and Regeneron and states that the content is the academy’s responsibility. That disclosure is recorded here rather than presenting the page as a conflict-free independent synthesis.[4]

Food allergy and eczema improvement are separate outcomes

The 2022 elimination-diet review combined ten randomized trials with 599 participants. The median of the studies’ mean ages was 1.5 years. Its authors described low-certainty evidence of a small possible eczema improvement; the population and uncertainty should remain visible rather than becoming an adult “root-cause” diet rule.[5]

Harms were inadequately measured in those trials. The authors also discussed indirect evidence of risks from indiscriminate avoidance, including developing IgE-mediated food allergy and delaying more effective treatment. A confirmed food allergy needs its own management, while an eczema diagnosis alone does not establish which food, if any, should be excluded.[5]

Colour, itch and texture should be considered together

Inflamed atopic skin may look red on lighter skin or brown, purple or gray on darker skin. Bumps, warmth, scratching and texture changes also matter. Residual lighter or darker colour after healing is different from an active flare, while thickened skin can remain itchy. Comparing only visible redness with a reference photograph can therefore miss important features.[6]

Bacteria on eczema skin do not automatically establish infection

Colonization means bacteria are present on skin without necessarily causing an infection that needs antibiotic treatment. The UK National Institute for Health and Care Excellence notes that eczema is often colonized, and that weeping or crusting alone does not settle whether a flare is bacterial. It also finds limited added benefit from routine antibiotics in people who are not systemically unwell. A clinician considers the whole pattern, severity and general health. A positive swab or a wet-looking patch should therefore not become an instruction to use leftover antibiotics or abandon the eczema care plan.[7]

A painful blistering eruption needs a different assessment from an ordinary flare

Eczema herpeticum is a potentially serious viral infection, usually caused by herpes simplex, that can spread over eczema-affected skin. Grouped painful blisters, rapid worsening, feeling unwell or eye discomfort deserve prompt medical assessment; seek urgent help if the eruption is worsening quickly or the eyes may be involved. It is not simply another name for bacterial infected eczema, and antibiotics do not treat the virus. Similar-looking eruptions can be difficult to distinguish, so do not wait for a home diagnosis or try leftover treatments.[8]

Evidence & uncertainty

Atopic dermatitis has established treatment approaches, but a universal dietary cure is not supported. A selected 2022 review found low-certainty evidence of small possible benefits from food elimination, mostly in young children, with unresolved harms. Its findings do not justify diagnosing food allergy or removing many foods from an eczema label alone.[5]

Selected-source overview · Independent review pending

Published questions

Is eczema always the same as atopic dermatitis?

Selected-source overview · Independent review pending. Read the evidence context.

No. Eczema includes several forms. Atopic dermatitis is one of them, and other forms can have different causes and management.[1]

Evidence behind this answer
  • Eczema types

    specialist patient explanation · Date not stated
    Selected relevant official page passages inspected · Atopic, contact, dyshidrotic and stasis categories

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can atopic dermatitis be caught through ordinary skin contact?

Selected-source overview · Independent review pending. Read the evidence context.

No. NIAMS describes it as noncontagious. Immune and barrier factors do not make it a person-to-person infection.[2]

Evidence behind this answer
  • Atopic Dermatitis

    agency patient explanation · 2022
    Selected relevant official page passages inspected · Immune/barrier factors, itch, age variation, noncontagiousness and skin appearance

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does atopic dermatitis occur only in children?

Selected-source overview · Independent review pending. Read the evidence context.

No. It can persist into adulthood or begin in adults. Age changes patterns and treatment considerations, rather than ruling it out.[2]

Evidence behind this answer
  • Atopic Dermatitis

    agency patient explanation · 2022
    Selected relevant official page passages inspected · Immune/barrier factors, itch, age variation, noncontagiousness and skin appearance

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Are moisturisers and anti-inflammatory eczema medicines interchangeable?

Selected-source overview · Independent review pending. Read the evidence context.

No. They address different aspects of care: barrier support and active inflammation. They may be used together under an appropriate plan.[4]

Evidence behind this answer
  • Atopic dermatitis: Diagnosis and treatment

    specialist patient explanation · Date not stated
    Selected relevant official page passages inspected · Barrier support, inflammatory treatment and content-support disclosure

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does eczema alone prove a food allergy that requires broad elimination?

Selected-source overview · Independent review pending. Read the evidence context.

No. Allergy and eczema are related but separate questions. The cited elimination-diet review found only small possible benefits with low-certainty evidence and unresolved harms.[5]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can a broad blood panel independently identify the cause of every eczema flare?

Selected-source overview · Independent review pending. Read the evidence context.

No. Diagnosis and selected testing depend on the history and examination. A test result must answer a specific clinical question.[3]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does an atopic-dermatitis treatment apply automatically to stasis or contact dermatitis?

Selected-source overview · Independent review pending. Read the evidence context.

No. Different eczema categories can involve circulation or contact exposures. The mechanism and diagnosis guide management.[1]

Evidence behind this answer
  • Eczema types

    specialist patient explanation · Date not stated
    Selected relevant official page passages inspected · Atopic, contact, dyshidrotic and stasis categories

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does finding bacteria on an eczema swab always mean I need antibiotics?

Selected-source overview · Independent review pending. Read the evidence context.

No. Eczema skin can carry bacteria without a clinical infection. Symptoms, severity and general health matter; a swab alone does not determine treatment.[7]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

References

  1. Eczema types

    Specialist patient explanation

    American Academy of Dermatology · Content/publication date: not stated
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Atopic, contact, dyshidrotic and stasis categories

  2. Atopic Dermatitis

    Agency patient explanation

    NIAMS · Content/publication date: 2022
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Immune/barrier factors, itch, age variation, noncontagiousness and skin appearance

    Page states last reviewed November 2022. Foundational explanation rather than a current complete prescribing comparison.

  3. Atopic Dermatitis: Diagnosis, Treatment, and Steps to Take

    Agency patient explanation

    NIAMS · Content/publication date: not stated
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Diagnosis and treatment categories including topical and systemic options

  4. Atopic dermatitis: Diagnosis and treatment

    Specialist patient explanation

    American Academy of Dermatology · Content/publication date: not stated
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Barrier support, inflammatory treatment and content-support disclosure

    Page acknowledges support from Sanofi and Regeneron and states that content is solely AAD’s responsibility. Not represented as an independent conflict-free trial synthesis.

  5. Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis

    Systematic review and meta analysis

    Oykhman P and colleagues · Content/publication date: 2022
    Accessed: 2026-10-07 UTC · Indexed original publication abstract inspected; direct retrieval unavailable
    Cited sections: Abstract: ten trials, age distribution, low-certainty small effects and inadequately measured harms

    Search through 18 January 2022. GRADE judgments are the review authors’. Harms evidence includes indirect findings; no Atlas full-text appraisal or exhaustive update completed.

  6. Atopic Dermatitis Symptoms

    Professional patient explanation

    AAD · Content/publication date: not stated
    Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
    Cited sections: Skin-tone-dependent appearance, itch, thickening and residual discoloration

  7. Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing, NICE NG190

    Official or original practical guidance

    National Institute for Health and Care Excellence · Content/publication date: 2021
    Accessed: 2026-10-20 UTC · Fresh full original recommendation book retrieved; colonization versus clinical infection, antibiotic-benefit boundary, HSV differential and referral sections read. Prescribing tables and doses are not adopted. Used to distinguish a flare from a diagnosis of bacterial infection.
    Cited sections: Recommendations 1.1.1–1.1.6 and reassessment/referral context

    Colonization and clinical infection differ; no home antimicrobial treatment plan.

  8. Eczema herpeticum

    Official or original practical guidance

    British Association of Dermatologists · Content/publication date: 2023
    Accessed: 2026-10-20 UTC · Fresh complete substantive original professional-society leaflet read, updated June 2023, with displayed June 2026 review due date now passed. Used for the distinct viral complication and assessment urgency, not a diagnosis, antiviral regimen or healing prediction. Web/PDF editions share one work.
    Cited sections: Definition; painful grouped blisters, eye symptoms and early/urgent assessment

    Potentially serious viral complication; prompt assessment, not self-diagnosis.

Scope & review

Population
General eczema literacy; elimination trials mostly young children
Exposure or intervention
Eczema categories, atopic dermatitis and selected treatment/diet evidence
Comparison
Barrier versus inflammatory care; elimination versus no elimination
Outcomes
Itch, skin severity, sleep and potential restriction harms
Timeframe
Chronic flares and trial-specific follow-up; selected 2022 review
Jurisdiction
US agency/specialist education and international research

Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-07 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
  • 2026-10-13 UTC: Deepened categories, selected primary-source evidence, comparator interpretation and scientific uncertainty; preserved prior IDs and citations.
  • 2026-10-20 UTC: Added selected-source concepts, product distinctions, practical assessment and treatment-plan questions after a full twenty-target care audit. Existing prose and anchors preserved; qualified review remains pending.

What this article still leaves open

  • Full current treatment guideline and long-term comparative safety appraisal by age and severity.
  • Separate contact, dyshidrotic, stasis and infected-eczema explanations; complete food-allergy assessment evidence.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.